Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$36K Buy
2,424
+1,000
+70% +$17.7K 0.01% 327
2016
Q3
$31K Buy
+1,424
New +$31.7K 0.01% 344
2016
Q2
Sell
-276
Closed -$5K 914
2016
Q1
$5K Sell
276
-320
-54% -$5.35K ﹤0.01% 650
2015
Q4
$12K Sell
596
-40
-6% -$832 ﹤0.01% 523
2015
Q3
$14K Buy
636
+32
+5% +$714 ﹤0.01% 496
2015
Q2
$12K Buy
+604
New +$10.6K ﹤0.01% 528

Other funds holding DXCM

Kanaly Trust's DXCM Position: Q4 2016 in Review

Kanaly Trust increased its DexCom (DXCM) stake by 70% in Q4 2016, buying an estimated $17.7K and bringing the position to 2,424 shares worth $36K. The position accounts for 0.01% of the portfolio, ranked #327.

Kanaly Trust first reported a position in DXCM in Q2 2015 and has held it in 6 quarters since. 315 funds tracked by Wall St. Rank hold DXCM as of Q4 2016.

  • Kanaly Trust held 2,424 shares of DexCom worth $36K as of Q4 2016.
  • Kanaly Trust bought 1,000 DexCom shares in Q4 2016, an estimated $17.7K.
  • DexCom made up 0.01% of Kanaly Trust's portfolio in Q4 2016, its #327 holding.
  • Kanaly Trust first reported a position in DexCom in Q2 2015 and has held it in 6 quarters since.
  • 315 funds tracked by Wall St. Rank held DexCom as of Q4 2016.

Based on Kanaly Trust's 13F filing for Q4 2016, filed 23 Jan 2017.